163 related articles for article (PubMed ID: 35738910)
1. FDG PET/CT for Primary Staging of Lung Cancer and Mesothelioma.
Kandathil A; Subramaniam RM
Semin Nucl Med; 2022 Nov; 52(6):650-661. PubMed ID: 35738910
[TBL] [Abstract][Full Text] [Related]
2. Whole-Body MRI: Comparison of Its Capability for TNM Staging of Malignant Pleural Mesothelioma With That of Coregistered PET/MRI, Integrated FDG PET/CT, and Conventional Imaging.
Ohno Y; Yui M; Aoyagi K; Kishida Y; Seki S; Koyama H; Yoshikawa T
AJR Am J Roentgenol; 2019 Feb; 212(2):311-319. PubMed ID: 30512992
[TBL] [Abstract][Full Text] [Related]
3. Loco-regional staging of malignant pleural mesothelioma by integrated
Murphy DJ; Mak SM; Mallia A; Jeljeli S; Stirling JJ; Goh V; Bille A; Cook GJR
Eur J Radiol; 2019 Jun; 115():46-52. PubMed ID: 31084758
[TBL] [Abstract][Full Text] [Related]
4.
Elliott HS; Metser U; de Perrot M; Cho J; Bradbury P; Veit-Haibach P; Hussey D; Noam T
Br J Radiol; 2018 Jun; 91(1086):20170814. PubMed ID: 29498536
[TBL] [Abstract][Full Text] [Related]
5. Present and future roles of FDG-PET/CT imaging in the management of malignant pleural mesothelioma.
Kitajima K; Doi H; Kuribayashi K
Jpn J Radiol; 2016 Aug; 34(8):537-47. PubMed ID: 27222020
[TBL] [Abstract][Full Text] [Related]
6. Does positron emission tomography offer prognostic information in malignant pleural mesothelioma?
Sharif S; Zahid I; Routledge T; Scarci M
Interact Cardiovasc Thorac Surg; 2011 May; 12(5):806-11. PubMed ID: 21266493
[TBL] [Abstract][Full Text] [Related]
7. The lung cancers: staging and response, CT,
Owens C; Hindocha S; Lee R; Millard T; Sharma B
Br J Radiol; 2023 Aug; 96(1148):20220339. PubMed ID: 37097296
[TBL] [Abstract][Full Text] [Related]
8. Utility of integrated computed tomography-positron emission tomography for selection of operable malignant pleural mesothelioma.
Wilcox BE; Subramaniam RM; Peller PJ; Aughenbaugh GL; Nichols Iii FC; Aubry MC; Jett JR
Clin Lung Cancer; 2009 Jul; 10(4):244-8. PubMed ID: 19632941
[TBL] [Abstract][Full Text] [Related]
9. Positron Emission Tomography/Computed Tomography for the Pleural Staging of Malignant Pleural Mesothelioma: How Accurate Is It?
Pinelli V; Roca E; Lucchini S; Laroumagne S; Loundou A; Dutau H; Maldonado F; Astoul P
Respiration; 2015; 89(6):558-64. PubMed ID: 25966972
[TBL] [Abstract][Full Text] [Related]
10. Malignant pleural mesothelioma: initial experience in integrated (18)F-FDG PET/MR imaging.
Schaarschmidt BM; Sawicki LM; Gomez B; Grueneisen J; Hoiczyk M; Heusch P; Buchbender C
Clin Imaging; 2016; 40(5):956-60. PubMed ID: 27232931
[TBL] [Abstract][Full Text] [Related]
11. Imaging of Malignant Pleural, Pericardial, and Peritoneal Mesothelioma.
Strange CD; Marom EM; Ahuja J; Shroff GS; Gladish GW; Carter BW; Truong MT
Adv Anat Pathol; 2023 Jul; 30(4):280-291. PubMed ID: 36395181
[TBL] [Abstract][Full Text] [Related]
12. Integrated positron emission tomography-computed tomography does not accurately stage intrathoracic disease of patients undergoing trimodality therapy for malignant pleural mesothelioma.
Pilling J; Dartnell JA; Lang-Lazdunski L
Thorac Cardiovasc Surg; 2010 Jun; 58(4):215-9. PubMed ID: 20514576
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of pretreatment volume-based quantitative
Kitajima K; Doi H; Kuribayashi K; Hashimoto M; Tsuchitani T; Tanooka M; Fukushima K; Nakano T; Hasegawa S; Hirota S
Eur J Radiol; 2017 Jan; 86():176-183. PubMed ID: 28027744
[TBL] [Abstract][Full Text] [Related]
14. ¹⁸F-FDG-PET/CT in malignant mesothelioma.
Fuccio C; Spinapolice EG; Ferretti A; Castellucci P; Marzola MC; Trifirò G; Rubello D
Biomed Pharmacother; 2013 Jul; 67(6):539-42. PubMed ID: 23583476
[TBL] [Abstract][Full Text] [Related]
15. FDG PET/CT is useful for detecting infiltration to the port site in patients with malignant pleural mesothelioma.
Kawaguchi K; Taniguchi T; Usami N; Fukui T; Ishiguro F; Nakamura S; Yokoi K
Gen Thorac Cardiovasc Surg; 2014 Mar; 62(3):157-62. PubMed ID: 24281913
[TBL] [Abstract][Full Text] [Related]
16. Clinical implications of 18F-fluorodeoxyglucose positron emission tomography/computed tomography at delayed phase for diagnosis and prognosis of malignant pleural mesothelioma.
Abe Y; Tamura K; Sakata I; Ishida J; Ozeki Y; Tamura A; Uematsu K; Sakai H; Goya T; Kanazawa M; Machida K
Oncol Rep; 2012 Feb; 27(2):333-8. PubMed ID: 22024889
[TBL] [Abstract][Full Text] [Related]
17. "PET/CT Variants and Pitfalls in Lung Cancer and Mesothelioma".
Lopci E; Kobe C; Gnanasegaran G; Adam JA; de Geus-Oei LF
Semin Nucl Med; 2021 Sep; 51(5):458-473. PubMed ID: 33993985
[TBL] [Abstract][Full Text] [Related]
18. Pleural tuberculosis mimicking malignant pleural mesothelioma by
Ai L; Wang W; Li Y
Med Clin (Barc); 2023 Nov; 161(9):415. PubMed ID: 37263842
[No Abstract] [Full Text] [Related]
19. Use of computed tomography and positron emission tomography/computed tomography for staging of local extent in patients with malignant pleural mesothelioma.
Frauenfelder T; Kestenholz P; Hunziker R; Nguyen TD; Fries M; Veit-Haibach P; Husmann L; Stahel R; Weder W; Opitz I
J Comput Assist Tomogr; 2015; 39(2):160-5. PubMed ID: 25354093
[TBL] [Abstract][Full Text] [Related]
20. Malignant pleural mesothelioma: utility of 18 F-FDG PET.
Spitilli MG; Treglia G; Calcagni ML; Giordano A
Ann Ital Chir; 2007; 78(5):393-6. PubMed ID: 18338546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
